跳至主要内容
临床试验/NCT00537992
NCT00537992已完成不适用

Blue Light-Filter IOLs in Vitrectomy Combined With Cataract Surgery: Results of a Randomized Controlled Clinical Trial.

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery0 个研究点目标入组 60 人开始时间: 2004年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
主要终点
intraoperative conditions for the surgeon (scaled questionnaire) and patients´ outcome

研究概览

简要总结

Although commonly used in cataract surgery, the use of the blue light-filter IOLs in vitrectomy combined with cataract surgery has not been reported yet. A prospective controlled clinical trial was designed to evaluate the effect of the blue light-filter IOL on the surgeon's ability to perform specific vitreoretinal procedures and on the patients' outcome.

详细描述

Sixty patients were randomly assigned to receive a UV-filter IOL (transparent IOL group) or a blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure.

Outcome measures were intraoperative conditions for the surgeon, complication rates, the functional outcome and vitreoretinal diagnoses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis vitreoretinal pathology (diabetic vitreous hemorrhage, macular hole, epiretinal membrane or persisting macula edema)
  • Coexisting significant cataract
  • The need for combined surgery ( pars plana vitrectomy, phacoemulsification and IOL implantation)
  • Age over 50 years.

排除标准

  • Pseudophakia on the non-study eye
  • The need for silicone oil tamponade
  • Optic atrophy.

结局指标

主要结局

intraoperative conditions for the surgeon (scaled questionnaire) and patients´ outcome

次要结局

  • complication rates and vitreoretinal diagnoses

研究者

发起方
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
申办方类型
Other

相似试验

Blue-Blocking IOLs in Combined Surgery | 临床试验